BRCA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.107600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.585400E-01
Normal-vs-Stage2
3.271000E-01
Normal-vs-Stage3
8.754000E-01
Normal-vs-Stage4
2.721000E-01
Stage1-vs-Stage2
3.066400E-01
Stage1-vs-Stage3
1.691210E-01
Stage1-vs-Stage4
4.279200E-01
Stage2-vs-Stage3
1.840850E-01
Stage2-vs-Stage4
9.062400E-01
Stage3-vs-Stage4
1.922600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.046800E-01
Normal-vs-AfricanAmerican
5.082200E-01
Normal-vs-Asian
4.720400E-01
Caucasian-vs-AfricanAmerican
8.856200E-01
Caucasian-vs-Asian
4.054800E-01
AfricanAmerican-vs-Asian
6.744200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.409000E-01
Normal-vs-Female
2.833400E-01
Male-vs-Female
2.251000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.017600E-01
Normal-vs-Age(41-60Yrs)
3.538800E-01
Normal-vs-Age(61-80Yrs)
3.212600E-01
Normal-vs-Age(81-100Yrs)
9.605800E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.911800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.930800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.236000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.624600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.352400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.111600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.474000E-01
Normal-vs-Daily Drinker
2.033800E-01
Normal-vs-Weekly Drinker
2.878600E-01
Normal-vs-Occasional Drinker
2.675200E-01
Normal-vs-Social Drinker
2.747200E-01
Non Drinker-vs-Daily Drinker
1.934610E-01
Non Drinker-vs-Weekly Drinker
1.053790E-01
Non Drinker-vs-Occasional Drinker
2.340800E-01
Non Drinker-vs-Social Drinker
3.874000E-01
Daily Drinker-vs-Weekly Drinker
5.126000E-01
Daily Drinker-vs-Occasional Drinker
9.715400E-01
Daily Drinker-vs-Social Drinker
7.512000E-01
Weekly Drinker-vs-Occasional Drinker
5.283800E-01
Weekly Drinker-vs-Social Drinker
4.060400E-01
Occasional Drinker-vs-Social Drinker
7.568600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.878200E-01
Normal-vs-Grade 2
7.268800E-01
Normal-vs-Grade 3
7.394200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.480000E-01
Grade 1-vs-Grade 3
2.031800E-01
Grade 1-vs-Grade 4
6.878200E-01
Grade 2-vs-Grade 3
6.656200E-01
Grade 2-vs-Grade 4
7.268800E-01
Grade 3-vs-Grade 4
7.394200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.119200E-01
Normal-vs-NonDiabetic
2.767400E-01
Diabetic-vs-NonDiabetic
4.497600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.325810E-01
Normal-vs-NoPancreatitis
3.824800E-01
Pancreatitis-vs-NoPancreatitis
3.241400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.195000E-01
Normal-vs-N1
3.453600E-01
N0-vs-N1
4.003000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.569500E-02
Normal-vs-TP53-NonMutant
2.485200E-01
TP53-Mutant-vs-TP53-NonMutant
1.698140E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
